{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:06:44Z","timestamp":1774645604221,"version":"3.50.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Fibroblast growth factor (FGF) 19 subfamily, also known as endocrine fibroblast growth factors (FGFs), is a newly discovered metabolic regulator, including FGF19, FGF21 and FGF23. They play significant roles in maintaining systemic homeostasis, regulating the balance of bile acid and glucolipid metabolism in humans. Osteoporosis is a chronic disease, especially in the current status of aging population, osteoporosis is the most prominent chronic bone disease, leading to multiple complications and a significant economic burden that requires long-term or even lifelong management. Members of the FGF family have been shown to be associated with bone mineral density (BMD), fracture repair and cartilage regeneration. Studies of the FGF19 subfamily in different populations with osteoporosis have been increasing in recent years. This review summarizes the role of the FGF19 subfamily in bone metabolism, and provides new options for the treatment of bone diseases such as osteoporosis.<\/jats:p>","DOI":"10.3389\/fendo.2022.830022","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T15:48:26Z","timestamp":1651160906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiawen","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1602599","article-title":"Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0339-7","article-title":"A Broader Strategy for Osteoporosis Interventions","volume":"16","author":"Reid","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of Osteoporosis: Concepts, Conflicts, and Prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-020-00600-8","article-title":"Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases","volume":"18","author":"Colaianni","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040932","article-title":"The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review","volume":"10","author":"Novais","year":"2021","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.05.022","article-title":"FGF-2 Targets Sclerostin in Bone and Myostatin in Skeletal Muscle to Mitigate the Deleterious Effects of Glucocorticoid on Musculoskeletal Degradation","volume":"229","author":"Adhikary","year":"2019","journal-title":"Life Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200409182","article-title":"Sox2 Induction by FGF and FGFR2 Activating Mutations Inhibits Wnt Signaling and Osteoblast Differentiation","volume":"168","author":"Mansukhani","year":"2005","journal-title":"J Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28946","article-title":"Muscle-Bone Crosstalk and Potential Therapies for Sarco-Osteoporosis","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.12.002","article-title":"Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases","volume":"40","author":"Luo","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic Potential of the Endocrine Fibroblast Growth Factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.02.013","article-title":"Alteration in the Serum Concentrations of FGF19, FGFR4 and \u03b2Klotho in Patients with Thyroid Cancer","volume":"105","author":"Motylewska","year":"2018","journal-title":"Cytokine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.canlet.2020.11.026","article-title":"FGF21 in Obesity and Cancer: New Insights","volume":"499","author":"Lu","year":"2021","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183727","article-title":"Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism","volume":"75","author":"Hu","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature25451","article-title":"\u03b1-Klotho Is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signalling","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000380970","article-title":"Klotho\/FGF23 Axis in CKD","volume":"185","author":"Tsuchiya","year":"2015","journal-title":"Contrib Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature25010","article-title":"Structures of \u03b2-Klotho Reveal A \u2019Zip Code\u2019-Like Mechanism for Endocrine FGF Signalling","volume":"553","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/\u03b2-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein And Glycogen Synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e1486","article-title":"Association between Bile Acid Metabolism and Bone Mineral Density in Postmenopausal Women","volume":"75","author":"Zhao","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.568500","article-title":"Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women","volume":"11","author":"Ramanjaneya","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2016.12.024","article-title":"Fibroblast Growth Factor 21 and Its Novel Association With Oxidative Stress","volume":"11","author":"G\u00f3mez-S\u00e1mano","year":"2017","journal-title":"Redox Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.06.012","article-title":"FGF21 Regulates Insulin Sensitivity Following Long-Term Chronic Stress","volume":"16","author":"Jelenik","year":"2018","journal-title":"Mol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"ra113","DOI":"10.1126\/scisignal.aab3715","article-title":"Activation of Mtorc1 in Skeletal Muscle Regulates Whole-Body Metabolism Through FGF21","volume":"8","author":"Guridi","year":"2015","journal-title":"Sci Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2015.09.018","article-title":"Fibroblast Growth Factor-21, Energy Balance and Obesity","author":"Giralt","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00037","article-title":"Fibroblast Growth Factor 21 and Browning of White Adipose Tissue","volume":"10","author":"Cuevas-Ramos","year":"2019","journal-title":"Front Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2018.08.005","article-title":"Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women","volume":"22","author":"Hu","year":"2019","journal-title":"J Clin Densitom"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01337-y","article-title":"Potential Role of Fibroblast Growth Factor 21 in the Deterioration of Bone Quality in Impaired Glucose Tolerance","volume":"44","author":"Lui","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12020-017-1507-y","article-title":"Association between Fibroblast Growth Factor 21 and Bone Mineral Density in Adults","volume":"59","author":"Hao","year":"2018","journal-title":"Endocrine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228810","article-title":"New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis","volume":"21","author":"Mace","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.601006","article-title":"Role of Fibroblast Growth Factor 23 (FGF23) and \u03b1Klotho in Cancer","volume":"8","author":"Ewendt","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12882-020-01826-5","article-title":"Interaction between Serum FGF-23 and PTH in Renal Phosphate Excretion, A Case-Control Study in Hypoparathyroid Patients","volume":"21","author":"Saki","year":"2020","journal-title":"BMC Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/a-1263-0898","article-title":"Metabolic Syndrome Pathophysiology and Predisposing Factors","volume":"42","author":"Bovolini","year":"2021","journal-title":"Int J Sports Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cells8050451","article-title":"Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects","volume":"8","author":"Colaianni","year":"2019","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.3390\/ijerph16183313","article-title":"The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells","volume":"16","author":"Wong","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11657-019-0615-0","article-title":"Associations of Obesity with Osteoporosis and Metabolic Syndrome in Korean Postmenopausal Women: A Cross-Sectional Study Using National Survey Data","volume":"14","author":"Kim","year":"2019","journal-title":"Arch Osteoporos"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S275560","article-title":"Relationship Between Metabolic Syndrome and Bone Health - An Evaluation of Epidemiological Studies and Mechanisms Involved","volume":"13","author":"Chin","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4311","article-title":"The Effect of Bolus Vitamin D(3) Supplementation on Distal Radius Fracture Healing: A Randomized Controlled Trial Using HR-pQCT","volume":"36","author":"Heyer","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3597-19","article-title":"Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients","volume":"59","author":"Yamamoto","year":"2020","journal-title":"Intern Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1774","article-title":"Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid","volume":"61","author":"Kasai","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0404-z","article-title":"Osteoporosis, Bone Mineral Density and CKD-MBD: Treatment Considerations","volume":"30","author":"Bover","year":"2017","journal-title":"J Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"115554","DOI":"10.1016\/j.bone.2020.115554","article-title":"Fractures After Kidney Transplantation: Incidence, Predictors, and Association with Mortality","volume":"140","author":"Iseri","year":"2020","journal-title":"Bone"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2020.03.030","article-title":"High Serum Fibroblast Growth Factor 23 Level Is Associated With Metabolic Syndrome in Kidney Transplantation Patients","volume":"52","author":"Chen","year":"2020","journal-title":"Transplant Proc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical Practice. Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in Older Adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med Clin North Am"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/ijerph18031200","article-title":"Bone Mineral Density in Different Menopause Stages Is Associated with Follicle Stimulating Hormone Levels in Healthy Women","volume":"18","author":"Park","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast Growth Factor 21 Promotes Bone Loss by Potentiating the Effects of Peroxisome Proliferator-Activated Receptor \u03b3","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/ijms22094495","article-title":"Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2936","article-title":"FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPAR\u03b1 and PPAR\u03b3 Agonists","volume":"32","author":"Li","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/1471-2296-14-145","article-title":"The Relationship Between Fibroblast Growth Factor 23 and Osteoporosis in Postmenopausal Women","volume":"104","author":"Celik","year":"2013","journal-title":"Minerva Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-010-9414-8","article-title":"Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1-34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation","volume":"87","author":"Sridharan","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1961","article-title":"Positive Regulation of Osteogenesis by Bile Acid through FXR","volume":"28","author":"Cho","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1900593","article-title":"Depletion of Gut Microbiota Induces Skeletal Muscle Atrophy by FXR-FGF15\/19 Signalling","volume":"53","author":"Qiu","year":"2021","journal-title":"Ann Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1038\/s41467-020-17363-6","article-title":"An FGF15\/19-TFEB Regulatory Loop Controls Hepatic Cholesterol and Bile Acid Homeostasis","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3652","article-title":"Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice","volume":"34","author":"Li","year":"2019","journal-title":"J Bone Miner Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04892-0","article-title":"Discovery of Potential Biomarkers for Osteoporosis using LC-MS\/MS Metabolomic Methods","volume":"30","author":"Wang","year":"2019","journal-title":"Osteoporos Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00075","article-title":"Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment","volume":"10","author":"Schiellerup","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0405","article-title":"Hormonal Alterations in PCOS and its Influence on Bone Metabolism","volume":"232","author":"Krishnan","year":"2017","journal-title":"J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1396-0","article-title":"Insulin and Osteocalcin: Further Evidence for a Mutual Cross-Talk","volume":"59","author":"Bilotta","year":"2018","journal-title":"Endocrine"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13456","article-title":"Bone Markers in Polycystic Ovary Syndrome: A Multicentre Study","volume":"87","author":"Lingaiah","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0897.2003.00056.x","article-title":"Fibroblast Growth Factor (FGF), Intracellular Adhesion Molecule (sICAM-1) Level in Serum and Follicular Fluid of Infertile Women with Polycystic Ovarian Syndrome, Endometriosis and Tubal Damage, and their Effect on ICSI Outcome","volume":"50","author":"Hammadeh","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13048-018-0455-3","article-title":"Intrafollicular Fibroblast Growth Factor 13 in Polycystic Ovary Syndrome: Relationship with Androgen Levels and Oocyte Developmental Competence","volume":"11","author":"Liu","year":"2018","journal-title":"J Ovarian Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2014.900821","article-title":"Fibroblast Growth Factor 21 and its Relation to Metabolic Parameters in Women with Polycystic Ovary Syndrome","volume":"74","author":"Sahin","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.487587","article-title":"Serum Fibroblast Growth Factor 21 Levels in Polycystic Ovary Syndrome","volume":"26","author":"Gorar","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0539","article-title":"Circulating FGF21 Levels are Related to Nutritional Status and Metabolic but not Hormonal Disturbances in Polycystic Ovary Syndrome","volume":"172","author":"Olszanecka-Glinianowicz","year":"2015","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.830022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T15:48:31Z","timestamp":1651160911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.830022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":69,"alternative-id":["10.3389\/fendo.2022.830022"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.830022","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"830022"}}